Manipal Health Enterprises signs ₹130 cr deal to acquire Kinder Women's Hospital
Manipal Health Enterprises acquires Kinder Women's Hospital in Bengaluru for ₹130 crore. The 100-bed facility generated ₹20.75 crore in revenue as of March 2026. Deal closes within 90 days subject to approvals.
*this image is generated using AI for illustrative purposes only.
Manipal Health Enterprises Limited (formerly Manipal Health Enterprises Private Limited) has entered into a definitive agreement to acquire the entire business operations and assets of Kinder Women's Hospital and Fertility Centre. The Bengaluru-based facility, owned by Kindorama Healthcare Private Limited, will be acquired for a cash consideration of ₹130 crore.
The acquisition aligns with the company's strategic direction to expand its footprint in allied healthcare services. The target entity, commissioned in 2022, operates with a current capacity of 100 beds in the Doddanekundi Industrial Area.
Transaction Details
The business transfer agreement was executed on August 17, 2026. Completion of the deal is contingent upon fulfilling conditions precedent stipulated in the agreement, primarily involving statutory and customary approvals related to the change of ownership.
| Particulars | Details |
|---|---|
| Target Entity | Kinder Women's Hospital and Fertility Centre |
| Location | Doddanekundi Industrial Area, Bengaluru |
| Consideration | ₹130 crore (Cash) |
| Revenue (as of Mar 31, 2026) | ₹20.75 crore |
| Bed Capacity | 100 beds |
| Expected Completion | Within 90 days of execution |
What the Numbers Show
The acquisition price of ₹130 crore represents a significant premium relative to the target's disclosed revenue of ₹20.75 crore as of March 31, 2026. This valuation multiple suggests the buyer is pricing in future growth potential and strategic fit rather than just current earnings, a common pattern in healthcare asset acquisitions where brand value and specialized capacity (fertility services) drive worth beyond immediate top-line figures.
Regulatory Disclosures
The transaction does not involve any related party interests, and neither the promoters nor group companies hold an interest in the seller. The company notified the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further details are available on the company's website.
How will Manipal Health Enterprises plan to integrate Kinder Women's Hospital's specialized fertility services into its existing allied healthcare portfolio to drive cross-selling opportunities?
Given the high valuation multiple relative to current revenue, what specific growth metrics or EBITDA targets must the acquired asset achieve within the first 24 months to justify the ₹130 crore premium?
Will this acquisition signal a broader strategic shift for Manipal Health Enterprises towards consolidating niche specialty centers in tier-1 cities like Bengaluru, and are similar deals in the pipeline?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
